Submission for OMB Review; Comment Request; National Survey of Primary Care Physicians' Recommendations and Practice for Breast, Cervical, Colorectal, and Lung Cancer Screening, 19528-19529 [E6-5532]

Download as PDF 19528 Federal Register / Vol. 71, No. 72 / Friday, April 14, 2006 / Notices estimated annualized burden is summarized below. Type of respondents Number of respondents Frequency of responses Children (Assessment Instrument Pilot Test) .................................. Parents (Assessment Instrument Pilot Test) ................................... Children (Evaluation) ....................................................................... Parents (Evaluation: 1 Satisfaction Scale/6 Usage Logs) ............... 34 34 120 120 1 1 3 1 6 Total .......................................................................................... 308 ........................ Request for Comments Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and the assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Direct Comments to OMB Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, New Executive Office Building, room 1–235, Washington, DC 20503, Attention: Desk Officer for NIH. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact Dr. Cathrine Sasek, Coordinator, Science Education Program. Office of Science Policy and Communications, National Institute on Drug Abuse, 6001 Executive Blvd, Room 5237, Bethesda, MD 20892, or call non-toll-free number (301) 443– 6071; fax (301) 443–6277; or by e-mail to csasek@nida.nih.gov. Comments Due Date Comments regarding this information are best assured of having their full effect if received within 30 days of the date of this publication. Dated: April 10, 2006. Laura Rosenthal, Executive Officer, National Institute on Drug Abuse. [FR Doc. 06–3596 Filed 4–13–06; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health Submission for OMB Review; Comment Request; National Survey of Primary Care Physicians’ Recommendations and Practice for Breast, Cervical, Colorectal, and Lung Cancer Screening SUMMARY: Under the provisions of section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH), National Cancer Institute (NCI), has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on January 20, 2006, page 3309 and allowed 60-days for public comment. No public comments were received. The purpose of this notice is to allow an additional Estimated number of respondents Questionnaire wwhite on PROD1PC65 with NOTICES Average time per response Annual hour burden 0.75 1 0.5 0.5 0.25 25.5 34.0 180.0 240.0 ................................ 479.50 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Proposed Collection: Title: National Survey of Primary Care Physicians’ Recommendations and Practice for Breast, Cervical, Colorectal, and Lung Cancer Screening. Type of Information Collection Request: New. Need and Use of Information Collection: This study will obtain current, national data on primary care physicians’ knowledge, attitudes, recommendations, and practices related to screening for breast, cervical, colorectal, and lung cancer. There have been substantial changes in guidelines and/or technologies for these types of cancer screening in recent years. The data collected in this study will support and further NCI work in monitoring and evaluating providers’ cancer control knowledge, attitudes, and practices and their impact on population health, as well as enable monitoring of progress toward major cancer control goals. Two questionnaires, one covering breast and cervical cancer screening and the other colorectal and lung cancer screening, will be administered by mail or telephone to a randomly-selected national sample of primary care physicians. Frequency of Response: One Time. Affected Public: Medical practices, clinics, or other health care organizations. Type of Respondents: Primary Care Physicians. Burden estimates are as follows: Estimated number of responses per respondent Average burden hours per response Estimated total annual burden hours Breast & cervical cancer screening ................................................................. Colorectal & lung cancer screening ................................................................. 1250 1250 1 1 0.333 0.333 416.25 416.25 Total .......................................................................................................... ........................ ........................ ........................ 832.5 VerDate Aug<31>2005 17:29 Apr 13, 2006 Jkt 208001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\14APN1.SGM 14APN1 Federal Register / Vol. 71, No. 72 / Friday, April 14, 2006 / Notices There are no Capital Costs to report. There are no Operating or Maintenance Costs to report. Request for Comments: Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (a) Whether the proposed collection of information is necessary for the performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, New Executive Office Building, Room 10235, Washington, DC 20503, Attention: Desk Officer for NIH. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Dr. Carrie Klabunde, Epidemiologist, Division of Cancer Control and Population Sciences, National Cancer Institute, Executive Plaza North 4005, 6130 Executive Boulevard, Bethesda, Maryland 20892–7344 or call non-tollfree 301–402–3362 or E-mail your request, including your address, to: klabundc@mail.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication. Dated: April 4, 2006. Rachelle Ragland-Greene, National Institutes of Health, NCI Project Clearance Liaison. [FR Doc. E6–5532 Filed 4–13–06; 8:45 am] BILLING CODE 4101–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES wwhite on PROD1PC65 with NOTICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice VerDate Aug<31>2005 16:37 Apr 13, 2006 Jkt 208001 is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, Cancer Detection. Date: May 5, 2006. Time: 11 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, 6116 Executive Boulevard, Room 8125, Bethesda, MD. (Telephone Conference Call). Contact Person: Virginia P. Wray, PhD., Deputy Chief, Research Programs Review Branch, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8125, Bethesda, MD 20892–8328. 301/496– 9236. wrayv@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Spore in Breast Cancer Review. Date: May 16–18, 2006. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Shamala K. Srinivas, PhD., Scientific Review Administrator, Grants Review Branch, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Room 8133, Bethesda, MD 20892. 301/594–1224. Name of Committee: National Cancer Institute Initial Review Group, Subcommittee F—Manpower & Training. Date: June 13–14, 2006. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Old Town Alexandria, 1767 King Street, Alexandria, VA 22314. Contact Person: Lynn M. Amende, PhD., Scientific Review Administrator, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8105, Bethesda, MD 20892. 301–451–4759. amendel@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Clinical Cluster Review. Date: June 19–21, 2006. Time: 6 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878. PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 19529 Contact Person: Wlodek Lopaczynski, PhD., MD, Scientific Review Administrator, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8133, Bethesda, MD 20892. 301–594–1402. lopacw@mail.nih.gov. Name of Committee: National Cancer Institute Initial Review Group, Subcommittee A—Cancer Centers. Date: August 3–4, 2006. Time: 1 p.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: David E. Maslow, PhD., Scientific Review Administrator, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8117, Bethesda, MD 20892–7405. (301) 496–2330. dm65y@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: April 6, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–3568 Filed 4–13–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome Research Institute; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Council for Human Genome Research. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property E:\FR\FM\14APN1.SGM 14APN1

Agencies

[Federal Register Volume 71, Number 72 (Friday, April 14, 2006)]
[Notices]
[Pages 19528-19529]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-5532]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Public Health Service

National Institutes of Health


Submission for OMB Review; Comment Request; National Survey of 
Primary Care Physicians' Recommendations and Practice for Breast, 
Cervical, Colorectal, and Lung Cancer Screening

SUMMARY: Under the provisions of section 3507(a)(1)(D) of the Paperwork 
Reduction Act of 1995, the National Institutes of Health (NIH), 
National Cancer Institute (NCI), has submitted to the Office of 
Management and Budget (OMB) a request for review and approval of the 
information collection listed below. This proposed information 
collection was previously published in the Federal Register on January 
20, 2006, page 3309 and allowed 60-days for public comment. No public 
comments were received. The purpose of this notice is to allow an 
additional 30 days for public comment. The National Institutes of 
Health may not conduct or sponsor, and the respondent is not required 
to respond to, an information collection that has been extended, 
revised, or implemented on or after October 1, 1995, unless it displays 
a currently valid OMB control number.
    Proposed Collection: Title: National Survey of Primary Care 
Physicians' Recommendations and Practice for Breast, Cervical, 
Colorectal, and Lung Cancer Screening. Type of Information Collection 
Request: New. Need and Use of Information Collection: This study will 
obtain current, national data on primary care physicians' knowledge, 
attitudes, recommendations, and practices related to screening for 
breast, cervical, colorectal, and lung cancer. There have been 
substantial changes in guidelines and/or technologies for these types 
of cancer screening in recent years. The data collected in this study 
will support and further NCI work in monitoring and evaluating 
providers' cancer control knowledge, attitudes, and practices and their 
impact on population health, as well as enable monitoring of progress 
toward major cancer control goals. Two questionnaires, one covering 
breast and cervical cancer screening and the other colorectal and lung 
cancer screening, will be administered by mail or telephone to a 
randomly-selected national sample of primary care physicians. Frequency 
of Response: One Time. Affected Public: Medical practices, clinics, or 
other health care organizations. Type of Respondents: Primary Care 
Physicians. Burden estimates are as follows:

----------------------------------------------------------------------------------------------------------------
                                                                     Estimated
                                                     Estimated       number of        Average        Estimated
                  Questionnaire                      number of    responses  per   burden hours    total annual
                                                    respondents     respondent     per response    burden hours
----------------------------------------------------------------------------------------------------------------
Breast & cervical cancer screening..............            1250               1           0.333          416.25
Colorectal & lung cancer screening..............            1250               1           0.333          416.25
                                                 ---------------------------------------------------------------
    Total.......................................  ..............  ..............  ..............           832.5
----------------------------------------------------------------------------------------------------------------


[[Page 19529]]

    There are no Capital Costs to report. There are no Operating or 
Maintenance Costs to report.
    Request for Comments: Written comments and/or suggestions from the 
public and affected agencies are invited on one or more of the 
following points: (a) Whether the proposed collection of information is 
necessary for the performance of the functions of the agency, including 
whether the information shall have practical utility; (b) the accuracy 
of the agency's estimate of the burden of the proposed collection of 
information; (c) ways to enhance the quality, utility, and clarity of 
the information to be collected; and (d) ways to minimize the burden of 
the collection of information on respondents, including through the use 
of automated collection techniques or other forms of information 
technology.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, New Executive Office Building, Room 10235, Washington, DC 
20503, Attention: Desk Officer for NIH. To request more information on 
the proposed project or to obtain a copy of the data collection plans 
and instruments, contact: Dr. Carrie Klabunde, Epidemiologist, Division 
of Cancer Control and Population Sciences, National Cancer Institute, 
Executive Plaza North 4005, 6130 Executive Boulevard, Bethesda, 
Maryland 20892-7344 or call non-toll-free 301-402-3362 or E-mail your 
request, including your address, to: klabundc@mail.nih.gov.
    Comments Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 30-days 
of the date of this publication.

    Dated: April 4, 2006.
Rachelle Ragland-Greene,
National Institutes of Health, NCI Project Clearance Liaison.
[FR Doc. E6-5532 Filed 4-13-06; 8:45 am]
BILLING CODE 4101-01-P